Predicting Dropout and Outcome From Neuropsychological Functions in SUD Patients
NCT03220373 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2024-01-05
Summary
The aim of this project is to gain a more specific understanding of how different cognitive profiles predict residential treatment drop-out, treatment retention and post-treatment outcome in a population with Substance Use Disorder.
Conditions
- Substance Use Disorder (SUD)
Sponsors & Collaborators
-
Oslo University Hospital
lead OTHER
Principal Investigators
-
Espen Walderhaug, PhD · Oslo University Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-07
- Primary Completion
- 2029-12-31
- Completion
- 2029-12-31
Countries
- Norway
Study Locations
More Related Trials
-
fNIRs-based Neurofeedback to Reduce Relapse in pOUD/AUD
NCT03595293 ·Status: WITHDRAWN ·Phase: NA
-
Neurofeedback & Alcohol Dependence
NCT02486900 ·Status: COMPLETED ·Phase: NA
-
Development of a Selective ALDH2 Inhibitor to Treat AUD
NCT04311294 ·Status: WITHDRAWN ·Phase: PHASE2
-
Exploring Regulation and Function of Dopamine D3 Receptors in Alcohol Use Disorders: A [11C]-(+)-PHNO Study
NCT03037060 ·Status: COMPLETED ·Phase: NA
-
Training Inhibition in Alcohol Use Disorder
NCT03530384 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder
NCT00218725 ·Status: COMPLETED ·Phase: PHASE1
-
Neurofeedback Training of Metacognition in Subjects With Alcohol Use Disorder. Disorder Induces Neural Modifications: an Event-related Potentials Study
NCT05913518 ·Status: RECRUITING ·Phase: NA
-
Optimisation of Functional MRI-based Neurofeedback for Alcohol Use Disorders
NCT02406456 ·Status: COMPLETED ·Phase: NA
-
Brain Connectivity Between Networks Implied in Inhibition and Cue-reactivity in Alcohol Use Disorder
NCT05843435 ·Status: COMPLETED
-
Ketamine and Neurofeedback as Combined Therapeutic Interventions to Target Glutamatergic Neurotransmission in Alcohol Use Disorder
NCT06969937 ·Status: RECRUITING ·Phase: PHASE2
-
A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
NCT02061293 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Intervention in Alcohol Use Disorder
NCT02168400 ·Status: COMPLETED ·Phase: NA
-
Semantic Networks in Alcohol Use Disorder Patients: Exploratory Study
NCT05636033 ·Status: COMPLETED
-
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
NCT06160232 ·Status: RECRUITING ·Phase: PHASE2
-
Improving Social Functioning in People With Substance Use and Mental Health Disorders Using VR
NCT06677515 ·Status: RECRUITING ·Phase: NA
-
Sequence of Symptom Change During AUD or PTSD Treatment for Comorbid PTSD/AUD
NCT01663337 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Brain Stimulation of the Prefrontal Cortex in Substance Use Disorders
NCT05471154 ·Status: COMPLETED ·Phase: NA
-
Health Mobile Cognitive Stimulation in Alcohol Use Disorder
NCT01942954 ·Status: COMPLETED ·Phase: NA
-
Involvement of the Septal Nuclei of the Human Brain in Alcohol Use Disorder
NCT06866379 ·Status: RECRUITING ·Phase: NA
-
Deep Brain Stimulation for Alcohol Use Disorder
NCT05522751 ·Status: COMPLETED ·Phase: NA
-
Mindfulness-Based Relapse Prevention for Alcohol Use Disorders in Remission
NCT02147483 ·Status: COMPLETED ·Phase: NA
-
Cognitive Dysfunction in the Addictions Study - Project 4 (P4)
NCT06299787 ·Status: RECRUITING ·Phase: NA
-
Severe Alcohol-use Disorder: a tDCS and Response Inhibition Training Intervention
NCT03447054 ·Status: COMPLETED ·Phase: NA
-
Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
NCT05855668 ·Status: RECRUITING ·Phase: NA
-
tDCS to Prevent Relapse in Alcohol Use Disorder
NCT04990375 ·Status: COMPLETED ·Phase: NA